臨牀消化器内科 Vol.25 No.9(4)


特集名 自己免疫性膵炎
題名 血液検査
発刊年月 2010年 08月
著者 川 茂幸 信州大学総合健康安全センター
著者 浜野 英明 信州大学医学部消化器内科
著者 伊藤 哲也 信州大学医学部消化器内科
著者 尾崎 弥生 信州大学医学部消化器内科
著者 新倉 則和 信州大学医学部消化器内科
【 要旨 】 自己免疫性膵炎は発症に自己免疫学的機序が想定される膵炎で,閉塞性黄疸で発症することが多く,膵癌との鑑別が重要である.一般生化学検査では閉塞性黄疸に起因する異常,免疫グロブリンの異常,耐糖能障害・膵外分泌機能低下に起因する異常を認める.抗核抗体(ANA),リウマトイド因子(RF)が免疫系の活性化を反映して陽性となるが,疾患特異的なSS-A,SS-B,AMAが陽性となることはほとんどない.本症では血中IgG4が高率,特異的に上昇する.血清IgG4値は膵癌との鑑別に有用であり,疾患活動性の鋭敏な指標であるが,役割は不明である.その他の疾患活動性マーカーとして補体,免疫複合体,可溶性IL-2受容体が有用である.
Theme Autoimmune Pancreatitis
Title Serological Markers for Autoimmune Pancreatitis
Author Shigeyuki Kawa Center for Health, Safety and Environmental Management, Shinshu University
Author Hideaki Hamano Department of Gastroenterology, Shinshu University School of Medicine
Author Tetsuya Ito Department of Gastroenterology, Shinshu University School of Medicine
Author Yayoi Ozaki Department of Gastroenterology, Shinshu University School of Medicine
Author Norikazu Arakura Department of Gastroenterology, Shinshu University School of Medicine
[ Summary ] Autoimmune pancreatitis exhibits various immunological abnormalities, and is thought to be caused by autoimmune mechanisms. It is frequently associated with obstructive jaundice at the onset of symptoms and must be differentiated from pancreatic cancer. Blood tests generally indicate abnormalities related to obstructive jaundice and immunoglobulin, as well as pancreatic endocrine and exocrine dysfunctions. Positive rates for gammaglobulin, IgG and IgG4 are 60, 70 and 90%, respectively. IgE is elevated in 30-40% of cases, indicating the contribution of allergies. Elevated HbA1c and decreased BT-PABA are found in tests over 50% of the time. Antinuclear antibody and rheumatoid factors are sometimes positive, ranging from 30 to 50%. However, disease specific antibodies, such as anti-SSA (Ro) or anti-SSB (La) antibodies or antimitochodorial antibodies are generally negative. Serum IgG4 is frequently elevated and is specifically, useful for the differentiation of autoimmune pancreatitis from pancreatic cancer, indicating higher sensitivity and a specificity of over 90%. It is also a sensitive marker for disease activity and a useful predictor of relapse. However, its role in pathogenesis is unclear. Complement C3 and C4 levels decrease to 30-40%, indicating that the complement activating system is a classical pathway in operation. These levels are also useful as disease activity markers. Other disease activity markers are immune complex and soluble IL2 receptors.
戻る